Multinationals In China Need To Walk The Talk To Create A Compliance Culture-Execs
This article was originally published in PharmAsia News
Executive Summary
Multinational drug company executives in China say they are attempting to go beyond compliance to instill a culture of ethical behavior in organizations as authorities widen investigations into kickbacks and bribes. The executives said at a forum this week that just following the letter of the law is not enough.